Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors

Journal of Cellular Biochemistry

Volumn 62, Issue SUPPL. 24, 1996, Pages 92-106

  Linnoila, R Ilona ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cytomorphology; lung cancer cell lines; markers; neuroendocrine differentiation; tumors

Indexed keywords

TUMOR MARKER; BIOLOGICAL MARKER; TUMOR PROTEIN;

CANCER CELL; CARCINOID; CELL DIFFERENTIATION; CELL STRUCTURE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MONOLAYER CULTURE; NEUROSECRETORY CELL; PRIORITY JOURNAL; REVIEW; CELL CULTURE; CHEMISTRY; LUNG TUMOR; NEUROENDOCRINE TUMOR; PATHOLOGY; SECRETION; SMALL CELL CARCINOMA;

BIOLOGICAL MARKERS; CARCINOID TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL DIFFERENTIATION; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; NEUROENDOCRINE TUMORS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 33646958191     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.240630506     Document Type: Review

References (66)

1. Linnoila RI, Aisner SC (1994): Pathology of lung cancer: Exercise in classification (101 Refs). In Johnson BE, Johnson DH (eds): "Lung Cancer. Current Clinical Oncology." New York: John Wiley & Sons, pp 73-95.
2. Azzopardi JG (1959): Oat-cell carcinoma of the bronchus. J Pathol Bacteriol 78:513-519.
3. Hattori S, Matsuda M, Tateishi R, Tatsumi N, Terazawa T (1968): Oat-cell carcinoma of the lung containing serotonin granules. GANN 59:123-129.
4. Bensch KG, Corrin B, Pariente R, Spencer H (1968): Oat-cell carcinoma of the lung: Its origin and relationship to bronchial carcinoid. Cancer 22:1163-1172.
5. Matthews MJ, Kanhouwa S, Pickren J, Robinette D (1973): Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer. Cancer Chem Rep (Part 3) 63-67.
6. Green RA, Humphrey E, Close H, Patno ME (1969): Alkylating agents in bronchogenic carcinoma. Am J Med 46:516-525.
7. Oboshi S, Tsugawa S, Seido T, Shimosato Y, Koide T, Ishikawa S (1971): A new floating cell line derived from pulmonary carcinoma of oat cell type. GANN 62:505-516.
8. Gazdar A (1994): Cell culture of lung cancers. In Hay RJ, Park JG, Gazdar A (eds): "Atlas of Human Tumor Cell Lines." Orlando: Academic Press, Inc., pp 121-160.
9. Baillie-Johnson H, Twentyman PR, Fox NE, Walls GA, Workman P, Watson JV, Johnson N, Reeve JG, Bleehen NM (1985): Establishment and characterization of cell lines from patients with lung cancer (predominantly small cell carcinoma). Br J Cancer 52:495-504.
10. Engelhohn SAA, Spang-Thomsen M, Vindelov LL, Brunner N, Nielsen MH, Hirsch F, Nielsen A, Hansen HH (1986): Comparison of characteristics of human small cell carcinoma of the lung in patients, in vitro and transplanted into nude mice. Acta Pathol Microbiol (Scand) 94:325-336.
11. Sorenson GD, Pettengill OS (1980): Structural and functional characteristics of small cell carcinoma of the lung, in vitro and in vivo. Biol Cell 39:277-280.
12. Eggleston JC (1984): Bronchial carcinoids and their relationship to other pulmonary tumors with endocrine features. In Becker KL, Gazdar AF (eds): "The Endocrine Lung in Health and Diseases." Philadelphia: W.B. Saunders, pp 389-405.
13. Bensch KG, Gordon GB, Miller LR (1965): Electron microscopic and biochemical studies on the bronchial carcinoid tumor. Cancer 18:592-602.
14. Bensch KG, Bonikos DS, Hockberger PE (1976): Pulmonary carcinoid tumors in tissue and organ culture. Cancer 38:2006-2016.
15. Debons-Guillemin MC, Launay JM, Roseto A, Peries J (1982): Serotonin and histamine production by human carcinoid cells in culture. Cancer Res 42:1513-1516.
16. Pelletier G, Cortot A, Launay JM, Debons-Guillemain MC, Nemeth J, Le Charpentier Y, Celerier M, Modigliani R (1984): Serotonin-secreting and insulin-secreting ileal carcinoid tumor and the use of in vitro culture of tumoral cells Cancer 54:319-322.
17. Arrigoni MG, Woolner LB, Bernatz PE (1972): Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 64:413-421.
18. Berger CL, Goodwin G, Mendelsohn G, Eggleston C, Abeloff MD, Aisner S, Baylin SB (1981): Endocrine-related biochemistry in the spectrum of human lung carcinoma. J Clin Endocrinol Metab 53:422-429.
19. Linnoila RI, Piantadosi S, Ruckdeschel JC (1994): Impact of neuroendocrine differentiation in non-small cell lung cancer The LCSG experience. Chest 106:367S-371S.
20. Luster W, Gropp C, Kern HF, Haveman K (1985): Lung tumor cell lines synthesizing peptide hormones established from tumours of four histologic types: Characterization of the cell lines and analysis of their peptide hormone production. Br J Cancer 51:865-875.
21. Linnoila RI, Mulshine JL, Steinberg SM, Funa K, Matthews MJ, Cotelingam JD, Gazdar AF (1988): Neuroendocrine differentiation in endocrine and non-endocrine lung carcinomas. Am J Clin Pathol 90:641-652.
22. Oie HK, Russell EK, Carney DN, Gazdar AF (1996): Cell culture methods for the establishment of the NCI series of lung cancer cell lines. J Cell Biochem (Suppl).
23. Nylen ES, Becker KL (1990): The diffuse endocrine systems. In Becker KL (ed): "Principals and Practice of Endocrinology and Metabolism." Philadelphia: J.P. Lippincot, pp 1276-1283.
24. Polak JM (1993): Lung endocrine cell markers, peptides, and amines. Anat Rec 236:169-171.
25. Sunday ME, Kaplan LM, Motoyama E, Chin WW, Spindel ER (1988): Biology of disease: Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease. Lab Invest 59:5-24.
26. Baylin SB, Abeloff MD, Goodwin G, Carney DN, Gazdar AF (1980): Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture. Cancer Res 40:1990-1994.
27. Gazdar AF, Helman LJ, Israel MA, Russell EK, Linnoila RI, Mulshine JL, Schuller HM, Park JG (1988): Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res 48:4078-4082.
28. Simms E, Gazdar AF, Abrams PG, Minna JD (1980): Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. Cancer Res 40:4356-4363.
29. Carney DN, Bunn PA Jr, Gazdar AF, Pagan JA, Minna JD (1981): Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. Proc Natl Acad Sci USA 78:3185-3189.
30. Carney DN, Gazdar AF, Bepler G, Guccion J, Marangos PJ, Moody TW, Zweig MH, Minna JD (1985): Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2913-2923.
31. Gazdar AF, Carney DN, Nau MM, Minna JD (1985): Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological and growth properties. Cancer Res 45:2924-2930.
32. Gazdar AF, Minna JD (1996): The NCI series of cell lines: An historical perspective. J Biol Chem (Suppl).
33. Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Ghosh BC, Cotelingam JD, Johnson BE, Minna JD, Ihde DC (1990): Correlation of in vitro drug-sensitivity testing results with, response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial. J Natl Cancer Inst 82:117-124.
34. Shaw GL, Gazdar AF, Phelps R, Linnoila RI, Ihde DC, Johnson BE, Oie HK, Pass HI, Steinberg SM, Ghosh BC, Minna JD, Mulshine JL (1993): Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res 53:5181-5187.
35. Johnson BE, Salem C, Nesbitt J, Gazdar AF, Lesar M, Phelps R, Edison M, Linnoila RI, Phares J, Pass H, Mulshine JL, Minna JD, Glatstein E, Ihde DC (1993): Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin. Lung Cancer 9(Suppl 1):S21-S26.
36. Bunn PA, Lichter AS, Makuch RW, Cohen MH, Veach SR, Matthews MJ, Johnston-Anderson A, Edison M, Glatstein E, Minna JD, Ihde DC (1987): Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial. Ann Intern Med 106:655-662.
37. Ihde DC, Mulshine JL, Kramer BS, Steinberg SM, Linnoila RI, Gazdar AF, Edison M, Phelps RM, Lesar M, Phares JC, Grayson J, Minna JD, Johnson BE (1994): Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer J Clin Oncol 12:2022-2034.
38. Johnson BE, Bridges JD, Sobczeck M, Gray J, Linnoila R, Gazdar AF, Hankins L, Steinberg SM, Edison M, Frame JN, Pass H, Nesbitt J, Holden D, Mulshine J, Glatstein E, Ihde DC (1996): Patients with limited stage small cell lung cancer treated with concurrent twice daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine or in vitro selected therapy. J Clin Oncol 14:806-813.
39. Carney DN, Brower M, Bertness V, Oie HK (1984): Selective growth of human small cell lung cancer cell lines and clinical specimens in serum-free medium. In Barnes DW, Sirbasku DA, Sato G (eds): "Methods for Serum-Free Culture of Epithelial and Fibroblastic Cells." New York: Alan Liss, Inc., pp 57-71.
40. Saccomanno G, Saunders RP, Ellis H, Archer VE, Wood BG, Beckler PA (1963): Concentration of carcinoma or atypical cells in sputum. Acta Cytol 7:305-310.
41. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Linnoila RI, Matthews MJ, Bunn PA Jr, Carney D, Minna JD, Mulshine JL (1996): The NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem (Suppl).
42. Carney DN, Bepler G, Gazdar AF (1985): The serum-free establishment and in vitro growth properties of classic and variant small cell lung cancer cell lines. Rec Res Cancer Res 99:157-166.
43. Gazdar AF, Linnoila RI (1988): The pathology of lung cancer: Changing concepts and newer diagnostic techniques. Semin Oncol 15:215-225.
44. Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI (1990): A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res 50:6068-6074.
45. Deftos LJ, Linnoila RI, Burton DW, Leong SS, O'Connor DT, Murray SS, Gazdar AF (1988): Demonstration of chromogranin A in human neuroendocrine cell lines by immunohistology and immunoassay. Cancer 62:92-97.
46. Gazdar AF, Helman LJ, Israel MA, Russell EK, Linnoila RI, Mulshine JL, Schuller HM, Park JG (1988): Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res 48:4078-4082.
47. Helman LJ, Gazdar AF, Park JG, Cohen PS, Cotelingam JD, Israel MA (1988): Chromogranin A expression in normal and malignant human tissues. J Clin Invest 82:686-690.
48. Gazdar AF, Carney DN, Becker KL, Deftos LJ, Liang V, Go W, Marangos PJ, Moody TW, Wolfsen AR, Zweig MH (1985): Expression of peptide and other markers in lung cancer cell lines. Rec Res Cancer Res 99:168-174.
49. Broers JLV, Viallet J, Jensen SM, Pass H, Travis WD, Minna JD, Linnoila RI (1993): Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers. Am J Respir Cell Mol Biol 9:33-43.
50. Johnson BE, Russell E, Simmons AM, Phelps R, Steinberg SM, Ihde DC, Gazdar AF (1996). MYC family DNA amplification in 124 tumor cell lines from patients with small cell lung cancer. J Cell Biochem (Suppl) (in press).
51. De Leij L, Postmus PE, Buys CHCM, Elema JD, Ramaekers F, Poppema S, Brouwer M, van der Veen AY, Mesander G, The, TH (1985): Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res 45:6024-6033.
52. Bepler G, Jaques G, Haveman K, Koehler A, Johnson BE, Gazdar AF (1987): Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer. Cancer Res 47:1883-1891.
53. Graziano SL, Cowan BY, Carney DN, Bryke CR, Mitter NS, Johnson BE, Mark GE, Planas AT, Catino JJ, Comis RL, Poiesz BJ (1987): Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p. Cancer Res 47:2148-2155.
54. Harpole DH Jr, Feldman JM, Buchanan S, Young WG, Wolfe WG (1992): Bronchial carcinoid tumors: A retrospective analysis of 126 patients. Ann Thorac Surg 54:50-55.
55. Nylen ES, Linnoila RI, Snider RH, Tabassian AR, Becker KL (1987): Comparative studies of hamster calcitonin from pulmonary endocrine cells in vitro. Peptides 8:977-982.
56. Linnoila RI, Gazdar AF (1990): Non-small cell lung carcinoma with neuroendocrine features. Anat Pathol 18:1-5.
57. Travis WD, Linnoila RI, Tsokos M, Hitchcock CL, Cutler GB, Nieman L, Chrousos G, Pass H, Doppman J (1991): Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol 15:529-533.
58. Broers JLV, Jensen SM, Travis WD, Pass H, Whitsett JA, Singh G, Katyal SL, Gazdar AF, Minna JD, Linnoila RI (1992): Expression of surfactant associated protein-A and clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridation. Lab Invest 66:337-346.
59. Ball DW, Azzoli CG, Baylin SB, Chi D, Dou S, Donis-Keller H, Cumaraswmy A, Borges M, Nelkin BD (1993): Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA 90:5648-5652.
60. Ball DW, Borges M, Linnoila RI, van de Veldo HJK, Mabry M, Nelkin BD, Baylin SB (1996): Achaete-scute homolog 1 is a determinant of the normal and neoplastic pulmonary neuroendocrine cell phenotype. Proc Am Assoc Cancer Res 37:533.
61. van de Velde HJK, Senden NHM, Roskams TAD, Broers JLV, Ramaerkers FCS, Roebroek AJM, van de Ven WJM (1994): NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis. Cancer Res 54:4769-4776.
62. Lai S-L, Brauch H, Knutsen T, Johnson BE, Nau MM, Mitsudomi T, Tsai C-M, Whang-Peng J, Zbar B, Kaye FJ, Gazdar AF (1995): Molecular genetic characterization of neuroendocrine lung cancer cell lines. Anticancer Res 15:225-232.
63. Gazdar AF, Kadoyama C, Venzon D, Park J, Tsai C, Linnoila RI, Mulshine JL, Ihde DC, Giaccone G (1992): Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. J Natl Cancer Inst Monogr 13:191-196.
64. McDowell EM, Trump BF (1981): Pulmonary small cell carcinoma showing tripartite differentiation in individual cells. Hum Pathol 12:286-294.
65. Gazdar AF, Carney DN, Guccion JG, Baylin SB (1981): Small cell carcinoma of the lung: Cellular origin and relationship to other pulmonary tumors. In Greco FA, Oldham RK, Bunn PA Jr (eds): New York: Grune & Stratton, pp 145-175.
66. Shaw GL, Gazdar AF, Phelps R, Steinberg SM, Linnoila RI, Johnson BE, Oie HK, Russell EK, Ghosh BC, Pass HL, Minna JD, Mulshine JL, Ihde DC (1996): Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: Comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem (Suppl) (in press).